Dr. Steven Rosenberg

Dr. Steven Rosenberg

Chief, Surgery Branch/Senior Investigator
National Cancer Institute

Dr. Steven Rosenberg is Chief of Surgery at the National Cancer Institute.

Dr. Rosenberg pioneered the development of effective immunotherapies and gene therapies for patients with advanced cancers. His studies of the adoptive transfer of genetically modified lymphocytes have resulted in the regression of metastatic cancer in patients with melanoma, sarcomas and lymphomas.

His current research is aimed at defining the host immune response of patients to their cancers.

Treatment

Cancer Research Legend Urges Patients to Get Multiple Opinions

Treatment

The Promise of Immunotherapy for Cancer Treatment

Treatment

Fighting Cancer With the Body’s Own Cells: The Immunotherapy Revolution

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.